Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series

Anke Thümler1, Elke Miebach, Christina Lampe

  • 1Department of Psychiatry, University of Mainz, Mainz, Germany.

Abstract

Insights

Adult patients with mucopolysaccharidosis (MPS) VI, even with slow progression, experience significant morbidity affecting multiple organs. Early diagnosis and comprehensive management are crucial for these patients.

Area of Science:

  • Medical Genetics
  • Rare Diseases
  • Metabolic Disorders

Background:

  • Mucopolysaccharidosis (MPS) VI is a rare genetic disorder.
  • Adult patients with MPS VI often present with slowly progressing disease.
  • Understanding the clinical spectrum in adults is vital for management.

Purpose of the Study:

  • To evaluate the clinical features and general health status of adult patients diagnosed with MPS VI.
  • To identify common characteristics and severe morbidities in this population.

Main Methods:

  • Retrospective analysis of clinical data from adult MPS VI patients (≥18 years).
  • Inclusion of variables such as urinary glycosaminoglycan (uGAG) levels, mutation analysis, physical measurements, pulmonary function (FVC), endurance (6-minute walk test), cardiac function, and surgical interventions.
  • Data collected between September 2003 and October 2008.

Main Results:

  • Nine adult patients (19-29 years) with MPS VI were analyzed.
  • Patients exhibited reduced forced vital capacity (FVC), decreased endurance, cardiac valve abnormalities, and orthopedic issues.
  • High prevalence of corneal clouding, ENT interventions, and need for surgeries like craniocervical decompression were observed.

Conclusions:

  • Adult patients with slowly progressing MPS VI, despite an attenuated course, display significant multi-organ morbidity.
  • Disease manifestations are heterogeneous but share common characteristics.
  • Emphasizes the critical need for early diagnosis, consistent follow-up, and timely treatment.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...